Isolated mediastinal lymph node false positivity of [18f]- fluorodeoxyglucoseypositron emission tomography/computed tomography in patients with cervical cancer

International Journal of Gynecological Cancer

Volumn 23, Issue 2, 2013, Pages 337-342

  Onal, Cem ^a   Oymak, Ezgi ^a   Findikcioglu, Alper ^a   Reyhan, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cervical cancer; False positivity; Gynecological cancer; Metastasis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DISSEMINATED CANCER; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; MEDIASTINUM LYMPH NODE METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MEDIASTINAL NEOPLASMS; MEDIASTINOSCOPY; MEDIASTINUM; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; UTERINE CERVICAL NEOPLASMS;

EID: 84876260480     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31827e00cc     Document Type: Article

References (24)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Atahan IL, Onal C, Ozyar E, et al. Long-term outcome and prognostic factors in patients with cervical carcinoma: A retrospective study. Int J Gynecol Cancer. 2007;17:833-842.
3. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-880.
4. Kidd EA, Siegel BA, Dehdashti F, et al. Lymph node staging by positron emission tomography in cervical cancer: Relationship to prognosis. J Clin Oncol. 2010;28:2108-2113.
5. Moore DH, Blessing JA, McQuellon RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study. J Clin Oncol. 2004;22:3113-3119.
6. Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: A Gynecologic Oncology Group study. J Clin Oncol. 2009;27:4649-4655.
7. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT. Radiology. 2006;238:272-279.
8. Davies A, Tan C, Paschalides C, et al. FDG-PET maximum standardised uptake value is associated with variation in survival: Analysis of 498 lung cancer patients. Lung Cancer. 2007;55:75-78.
9. Schwarz JK, Siegel BA, Dehdashti F, et al. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2012;83:185-190.
10. Bakheet SM, Powe J, Kandil A, et al. F-18 FDG uptake in breast infection and inflammation. Clin Nucl Med. 2000;25:100-103.
11. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132:178S-201S.
12. Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung cancer: Novel concepts. Lancet Oncol. 2012;13:e221-e229.
13. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571-578.
14. Onal C, Arslan G, Topkan E, et al. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: Target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009;28:95.
15. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-1209.
16. Al-Sarraf N, Aziz R, Gately K, et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg. 2008;33:104-109.
17. Bille A, Pelosi E, Skanjeti A, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: Accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg. 2009;36:440-445.
18. Darling GE, Maziak DE, Inculet RI, et al. Positron emission tomographyYcomputed tomography compared with invasive mediastinal staging in non-small cell lung cancer: Results of mediastinal staging in the early lung positron emission tomography trial. J Thorac Oncol. 2011;6:1367-1372.
19. Davis SL, Nuermberger EL, Um PK, et al. Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob Agents Chemother. 2009;53:4879-4884.
20. Golden MP, Vikram HR. Extrapulmonary tuberculosis: An overview. Am Fam Physician. 2005;72:1761-1768.
21. Sathekge M, Maes A, Kgomo M, et al. Impact of FDG PET on the management of TBC treatment. A pilot study. Nuklearmedizin. 2010;49:35-40.
22. Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:202S-220S.
23. Smulders SA, Smeenk FW, Janssen-Heijnen ML et al. Surgical mediastinal staging in daily practice. Lung Cancer. 2005;47:243-251.
24. Cerfolio RJ, Ojha B, Bryant AS, et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78:1017-1023; discussion-23.